Drugplain

Phosphorus 30 [hp_C]/30[hp_C]

PHOSPHORUS · PELLET · Boiron

6 Recalls on Record
Plain English

Phosphorus is a pellet containing phosphorus at 30 [hp_C]/30[hp_C], taken oral. Manufactured by Boiron.

Key Facts

Brand Name
Phosphorus
Generic Name
PHOSPHORUS
NDC Code (Product)
0220-4036
Manufacturer
Boiron
Strength
30 [hp_C]/30[hp_C]
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
03/03/1983

Recall History

6 Recalls on Record
Class II08/20/2021

Washington Homeopathic Products, Inc.

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

TerminatedVoluntary: Firm initiated
Class II09/06/2013

Triangle Compounding

Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

TerminatedVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014; VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014; NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014; traZODone HCl, Tablet, 50 mg, NDC 50111043303, P

TerminatedVoluntary: Firm initiated
Class II08/20/2021

Washington Homeopathic Products, Inc.

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

TerminatedVoluntary: Firm initiated
Class II01/09/2014

Hospira Inc.

Lack of Assurance of Sterility; potential leakage from administrative port.

TerminatedVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup; CHOLECALCIFEROL/CALCIUM/PHOSPHORUS Tablet, 120 units/105 mg/81 mg may be potentially mislabeled as PROMETHAZINE HCL, Tablet, 25 mg, NDC 65162052110, Pedigree: W002578, EXP: 6/3/2014; VALSARTAN, Tablet, 40 mg, NDC 00078042315, Pedigree: AD32579_1, EXP: 5/9/2014.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

paraesthesia299 reports
hypoaesthesia292 reports
vomiting277 reports
abdominal pain upper247 reports
drug ineffective242 reports
taste disorder240 reports
gastrooesophageal reflux disease239 reports
pain239 reports
asthenia236 reports
drug intolerance236 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

FOR ORAL USE ONLY

Dosage & Administration

Directions: Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow. Follow inside instructions to open ampule.

Warnings

Warnings: NOT FOR INJECTION Do not use if allergic to any ingredient. Consult a physician if symptoms worsen. If pregnant or nursing, consult a physician before use. Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Frequently Asked Questions

What is Phosphorus used for?

Phosphorus contains PHOSPHORUS. It is a pellet taken oral. Consult your doctor for specific uses.

Is Phosphorus a controlled substance?

Phosphorus is not classified as a controlled substance by the DEA.

What is the generic name for Phosphorus?

The generic name for Phosphorus is PHOSPHORUS. There are 6 other brand versions of PHOSPHORUS.

What is the NDC code for Phosphorus 30 [hp_C]/30[hp_C]?

The NDC (National Drug Code) for Phosphorus 30 [hp_C]/30[hp_C] is 0220-4036, listed by Boiron.